Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unispire Biopharma is an Indian private pharmaceutical company that appears to operate primarily as a manufacturer and trader of finished pharmaceutical products rather than as a clinical-stage drug developer. Publicly available company-registry and B2B marketplace information indicates that it was incorporated in 2018 in Maharashtra, India, and remains active and privately held. Its marketed offerings appear to include pharmaceutical tablets, capsules, injections, immunoglobulin products, and related healthcare products. There is no clear evidence from readily available public sources that the company runs a disclosed R&D pipeline, named therapeutic platform, or clinical-stage biotech program. Based on available information, it is best characterized as a small commercial pharma company focused on product supply and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unispire Biopharma.